Skip to main content
Erschienen in: World Journal of Surgery 9/2018

16.03.2018 | Original Scientific Report

Changing Profile of Primary Hyperparathyroidism Over Two and Half Decades: A Study in Tertiary Referral Center of North India

verfasst von: Sanjay Kumar Yadav, Saroj Kanta Mishra, Anjali Mishra, Sabaretnam Mayilvagnan, Gyan Chand, Gaurav Agarwal, Amit Agarwal, Ashok Kumar Verma

Erschienen in: World Journal of Surgery | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Most of the cases of PHPT in developing countries present in symptomatic stage, some even in very advanced stage but in recent years the trend seems to be changing. This has been corroborated from few recently published literature from developing countries. The scope of this study is to further carry out an in-depth analysis of various clinical and biochemical parameters of PHPT patients at a tertiary care center of northern India.

Methods

In this retrospective analysis, a total of 333 patients with PHPT from the year 1990 to 2016 were studied. The study population was divided into three subgroups based on the time span; 1990–1999 (n = 34), 2000–2009 (n = 112), 2010–2016 (n = 187), and clinical and biochemical parameters were compared.

Results

The clinical presentation has evolved progressively with increase in older age group (35 vs 39 vs 43.85, p < 0.001), less patients with musculoskeletal symptoms (85.3 vs 76.8 vs 61%, p = 0.002) and less patients with severe bone disease (29.4 vs 10.7 vs 10.7%, p = 0.088). Biochemical parameters also showed a changing trend with significant decrease in mean S. Alkaline phosphatase (1393 vs 965 vs 414.8 IU/L, p < 0.001) and S. iPTH (837.52 vs 812.89 vs 635.74 pg/mL, p = 0.02). Vitamin D nutrition status is still suboptimal but shows improvement, and more patients are insufficient as compared to previous deficient state (mean S. Vitamin D—10.31 vs 16.16 vs 25.30 ng/mL, p < 0.001).

Conclusions

Our study reveals a change in trend in PHPT which is similar to evolution of this disease in western population and positively corroborated with observations from China, Hong Kong and Turkey.
Literatur
1.
Zurück zum Zitat Bilezikian JP, Silverberg SJ (2004) Asymptomatic primary hyperparathyroidism. N Engl J Med 350(17):1746–1751CrossRefPubMed Bilezikian JP, Silverberg SJ (2004) Asymptomatic primary hyperparathyroidism. N Engl J Med 350(17):1746–1751CrossRefPubMed
2.
Zurück zum Zitat Harinarayan CV, Gupta N, Kochupillai N (1995) Vitamin D status in primary hyperparathyroidism in India. Clin Endocrinol (Oxf) 43:351–358CrossRef Harinarayan CV, Gupta N, Kochupillai N (1995) Vitamin D status in primary hyperparathyroidism in India. Clin Endocrinol (Oxf) 43:351–358CrossRef
3.
Zurück zum Zitat Mishra SK, Agarwal G, Kar DK, Gupta SK, Mithal A, Rastad J (2001) Unique clinical characteristics of primary hyperparathyroidism in India. Br J Surg 88:708–714CrossRefPubMed Mishra SK, Agarwal G, Kar DK, Gupta SK, Mithal A, Rastad J (2001) Unique clinical characteristics of primary hyperparathyroidism in India. Br J Surg 88:708–714CrossRefPubMed
4.
Zurück zum Zitat Arya V, Bhambri R, Godbole MM, Mithal A (2004) Vitamin D status and its relationship with bone mineral density in healthy Asian Indians. Osteoporos Int 15:56–61CrossRefPubMed Arya V, Bhambri R, Godbole MM, Mithal A (2004) Vitamin D status and its relationship with bone mineral density in healthy Asian Indians. Osteoporos Int 15:56–61CrossRefPubMed
5.
Zurück zum Zitat Muthukrishnan J, Jha S, Modi KD, Jha R, Kumar J, Verma A et al (2008) Symptomatic primary hyperparathyroidism: a retrospective analysis of fifty one cases from a single centre. J Assoc Physicians India 56:503–507PubMed Muthukrishnan J, Jha S, Modi KD, Jha R, Kumar J, Verma A et al (2008) Symptomatic primary hyperparathyroidism: a retrospective analysis of fifty one cases from a single centre. J Assoc Physicians India 56:503–507PubMed
6.
Zurück zum Zitat Soin AS, Gupta S, Kochupillai N, Sharma LK (1994) Primary hyperparathyroidism—an Indian study. Indian J Cancer 31(2):72–77PubMed Soin AS, Gupta S, Kochupillai N, Sharma LK (1994) Primary hyperparathyroidism—an Indian study. Indian J Cancer 31(2):72–77PubMed
7.
Zurück zum Zitat Agarwal G, Mishra SK, Kar DK, Singh AK, Arya V, Gupta SK, Mithal A (2002) Recovery pattern of patients with osteitis fibrosa cystica in primary hyperparathyroidism after successful parathyroidectomy. Surgery 132(6):1075–1083 (discussion 1083-5)CrossRefPubMed Agarwal G, Mishra SK, Kar DK, Singh AK, Arya V, Gupta SK, Mithal A (2002) Recovery pattern of patients with osteitis fibrosa cystica in primary hyperparathyroidism after successful parathyroidectomy. Surgery 132(6):1075–1083 (discussion 1083-5)CrossRefPubMed
9.
Zurück zum Zitat Bhansali A, Masoodi SR, Reddy KS, Behera A, das Radotra B, Mittal BR, Katariya RN, Dash RJ (2005) Primary hyperparathyroidism in north India: a description of 52 cases. Ann Saudi Med 25(1):29–35CrossRefPubMed Bhansali A, Masoodi SR, Reddy KS, Behera A, das Radotra B, Mittal BR, Katariya RN, Dash RJ (2005) Primary hyperparathyroidism in north India: a description of 52 cases. Ann Saudi Med 25(1):29–35CrossRefPubMed
10.
Zurück zum Zitat Bilezikian JP, Meng X, Shi Y, Silverberg SJ (2000) Primary hyperparathyroidism in women: a tale of two cities-New York and Beijing. Int J Fertil Womens Med 45:158–165PubMed Bilezikian JP, Meng X, Shi Y, Silverberg SJ (2000) Primary hyperparathyroidism in women: a tale of two cities-New York and Beijing. Int J Fertil Womens Med 45:158–165PubMed
11.
Zurück zum Zitat Ohe MN, Santos RO, Barros ER et al (2006) Changes in clinical and laboratory findings at the time of diagnosis of primary hyperparathyroidism in a University Hospital in Sao Paulo from 1985–2002. Braz J Med Biol Res 38:1383–1387CrossRef Ohe MN, Santos RO, Barros ER et al (2006) Changes in clinical and laboratory findings at the time of diagnosis of primary hyperparathyroidism in a University Hospital in Sao Paulo from 1985–2002. Braz J Med Biol Res 38:1383–1387CrossRef
12.
Zurück zum Zitat Biyabani SR, Talati J (1999) Bone and renal stone disease in patients operated for primary hyperparathyroidism in Pakistan: is the pattern of disease different from the west? J Pak Med Assoc 49:194–198PubMed Biyabani SR, Talati J (1999) Bone and renal stone disease in patients operated for primary hyperparathyroidism in Pakistan: is the pattern of disease different from the west? J Pak Med Assoc 49:194–198PubMed
13.
Zurück zum Zitat Gopal RA et al (2010) Clinical profile of primary hyperparathyroidism from western India: a single center experience. J Postgrad Med 56:79–84CrossRefPubMed Gopal RA et al (2010) Clinical profile of primary hyperparathyroidism from western India: a single center experience. J Postgrad Med 56:79–84CrossRefPubMed
14.
Zurück zum Zitat Eufrazino C, Veras A, Bandeira F (2013) Epidemiology of primary hyperparathyroidism and its non-classical manifestations in the city of Recife, Brazil. Clin Med Insights: Endocrinol Diabetes 6:69–74 Eufrazino C, Veras A, Bandeira F (2013) Epidemiology of primary hyperparathyroidism and its non-classical manifestations in the city of Recife, Brazil. Clin Med Insights: Endocrinol Diabetes 6:69–74
15.
Zurück zum Zitat Paruk IM, Esterhuizen TM, Maharaj S, Pirie FJ, Motala AA (2013) Characteristics, management and outcome of primary hyperparathyroidism in South Africa: a single-centre experience. Postgrad Med J 89:626–631CrossRefPubMed Paruk IM, Esterhuizen TM, Maharaj S, Pirie FJ, Motala AA (2013) Characteristics, management and outcome of primary hyperparathyroidism in South Africa: a single-centre experience. Postgrad Med J 89:626–631CrossRefPubMed
16.
Zurück zum Zitat Marcocci C, Bollerslev J, Khan AA, Shoback DM (2014) Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism. J Clin Endocrinol Metab 99:3607–3618CrossRefPubMed Marcocci C, Bollerslev J, Khan AA, Shoback DM (2014) Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism. J Clin Endocrinol Metab 99:3607–3618CrossRefPubMed
17.
Zurück zum Zitat Lowe H, McMahon DJ, Rubin MR, Bilezikian JP, Silverberg SJ (2007) Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab 92:3001–3005CrossRefPubMed Lowe H, McMahon DJ, Rubin MR, Bilezikian JP, Silverberg SJ (2007) Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab 92:3001–3005CrossRefPubMed
18.
Zurück zum Zitat Berger C et al (2015) Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers. Clin Endocrinol (Oxf) 82:359–368CrossRef Berger C et al (2015) Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers. Clin Endocrinol (Oxf) 82:359–368CrossRef
19.
Zurück zum Zitat Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G, Oppo A, Miccoli P, Berti P, Bilezikian JP, Pinchera A, Marcocci C (2007) Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 92(3114–21):6 Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G, Oppo A, Miccoli P, Berti P, Bilezikian JP, Pinchera A, Marcocci C (2007) Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 92(3114–21):6
20.
Zurück zum Zitat Bollerslev J, Jansson S, Mollerup CL, Nordenstrom J, Lundgren E, Torring O, Varhaug JE, Baranowski M, Aanderud S, Franco C, Freyschuss B, Isaksen GA, Ueland T, Rosen T (2007) Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 92(1687–92):7 Bollerslev J, Jansson S, Mollerup CL, Nordenstrom J, Lundgren E, Torring O, Varhaug JE, Baranowski M, Aanderud S, Franco C, Freyschuss B, Isaksen GA, Ueland T, Rosen T (2007) Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 92(1687–92):7
21.
Zurück zum Zitat Rao DS, Phillips ER, Divine GW, Talpos GB (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89(5415–22):8 Rao DS, Phillips ER, Divine GW, Talpos GB (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89(5415–22):8
22.
Zurück zum Zitat Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E, Udesky J, Silverberg SJ (2008) The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab 93(3462–70):9 Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E, Udesky J, Silverberg SJ (2008) The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab 93(3462–70):9
23.
Zurück zum Zitat Lundstam K, Heck A, Mollerup C, Godang K, Baranowski M, Pernow Y, Varhaug JE, Hessman O, Rosen T, Nordenstrom J, Jansson S, Hellstrom M, Bollerslev J (2015) Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism. J Clin Endocrinol Metab 100:1359–1367CrossRefPubMed Lundstam K, Heck A, Mollerup C, Godang K, Baranowski M, Pernow Y, Varhaug JE, Hessman O, Rosen T, Nordenstrom J, Jansson S, Hellstrom M, Bollerslev J (2015) Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism. J Clin Endocrinol Metab 100:1359–1367CrossRefPubMed
24.
Zurück zum Zitat Shah VN, Bhadada SK, Bhansali A, Behera A, Mittal BR (2014) Changes in clinical & biochemical presentations of primary hyperparathyroidism in India over a period of 20 years. Indian J Med Res 139:694–699PubMedPubMedCentral Shah VN, Bhadada SK, Bhansali A, Behera A, Mittal BR (2014) Changes in clinical & biochemical presentations of primary hyperparathyroidism in India over a period of 20 years. Indian J Med Res 139:694–699PubMedPubMedCentral
25.
Zurück zum Zitat Zhao Lin, Liu Jian-min, He Xiao-Yan, Zhao Hong-yan, Sun Li-hao, Tao Bei, Zhang Min-jia, Chen Xi, Wang Wei-qing, Ning Guang (2013) The changing clinical patterns of primary hyperparathyroidism in chinese patients: data from 2000 to 2010 in a single clinical center. J Clin Endocrinol Metab 98(2):721–728CrossRefPubMed Zhao Lin, Liu Jian-min, He Xiao-Yan, Zhao Hong-yan, Sun Li-hao, Tao Bei, Zhang Min-jia, Chen Xi, Wang Wei-qing, Ning Guang (2013) The changing clinical patterns of primary hyperparathyroidism in chinese patients: data from 2000 to 2010 in a single clinical center. J Clin Endocrinol Metab 98(2):721–728CrossRefPubMed
26.
Zurück zum Zitat Prasarttong-Osoth Poramaporn, Wathanaoran Pakpong, Imruetaicharoenchoke Waraporn, Rojananin Supakorn (2012) Primary hyperparathyroidism: 11-year experience in a single institute in Thailand. Int J Endocrinol 2012:952426CrossRefPubMedPubMedCentral Prasarttong-Osoth Poramaporn, Wathanaoran Pakpong, Imruetaicharoenchoke Waraporn, Rojananin Supakorn (2012) Primary hyperparathyroidism: 11-year experience in a single institute in Thailand. Int J Endocrinol 2012:952426CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Bahrami A (2008) Primary hyperparathyroidism in Iran: a review. Int J Endocrinol Metab 1:50–57 Bahrami A (2008) Primary hyperparathyroidism in Iran: a review. Int J Endocrinol Metab 1:50–57
28.
Zurück zum Zitat Younes Nidal A, Al-Trawneh Imad S, Albesoul Nader M, Hamdan Bassem R, Sroujieh Ahmad S (2003) Clinical spectrum of primary hyperparathyroidism. Saudi Med J 24(2):179–183PubMed Younes Nidal A, Al-Trawneh Imad S, Albesoul Nader M, Hamdan Bassem R, Sroujieh Ahmad S (2003) Clinical spectrum of primary hyperparathyroidism. Saudi Med J 24(2):179–183PubMed
29.
Zurück zum Zitat Government of India (2014) National health policy draft. Ministry of Health and Family Welfare, Government of India, New Delhi Government of India (2014) National health policy draft. Ministry of Health and Family Welfare, Government of India, New Delhi
31.
Zurück zum Zitat Ghosh S (2014) Publicly-financed health insurance for the poor understanding RSBY in Maharashtra. Econ Polit Wkly 49:93–99 Ghosh S (2014) Publicly-financed health insurance for the poor understanding RSBY in Maharashtra. Econ Polit Wkly 49:93–99
32.
Zurück zum Zitat Shah VN, Bhadada SK, Bhansali A, Behera A, Mittal BR, Bhavin V (2012) Influence of age and gender on presentation of symptomatic primary hyperparathyroidism. J Postgrad Med 58:107–111CrossRefPubMed Shah VN, Bhadada SK, Bhansali A, Behera A, Mittal BR, Bhavin V (2012) Influence of age and gender on presentation of symptomatic primary hyperparathyroidism. J Postgrad Med 58:107–111CrossRefPubMed
34.
Zurück zum Zitat Jha S, Jayaraman M, Jha A, Jha R, Modi KD, Kelwadee JV (2016) Primary hyperparathyroidism: a changing scenario in India. Indian J Endocrinol Metab 20(1):80–83CrossRefPubMedPubMedCentral Jha S, Jayaraman M, Jha A, Jha R, Modi KD, Kelwadee JV (2016) Primary hyperparathyroidism: a changing scenario in India. Indian J Endocrinol Metab 20(1):80–83CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Liu JM, Cusano NE, Silva BC, Zhao L, He XY, Tao B, Sun LH, Zhao HY, Fan WW, Romano ME, Ning G, Bilezikian JP (2013) Primary hyperparathyroidism: a tale of two cities revisited—New York and Shanghai. Bone Res 1(2):162–169CrossRefPubMedPubMedCentral Liu JM, Cusano NE, Silva BC, Zhao L, He XY, Tao B, Sun LH, Zhao HY, Fan WW, Romano ME, Ning G, Bilezikian JP (2013) Primary hyperparathyroidism: a tale of two cities revisited—New York and Shanghai. Bone Res 1(2):162–169CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Raue F, Jacubeit T, Minne H, Herfarth C, Ziegler R (1989) Primary hyperparathyroidism–changes in the disease picture. Med Klin (Munich) 84(4):178–182 Raue F, Jacubeit T, Minne H, Herfarth C, Ziegler R (1989) Primary hyperparathyroidism–changes in the disease picture. Med Klin (Munich) 84(4):178–182
39.
Zurück zum Zitat Sivula A, Ronni-Sivula H (1984) The changing picture of primary hyperparathyroidism in the years 1956–1979. Ann Chir Gynaecol 73(6):319–324PubMed Sivula A, Ronni-Sivula H (1984) The changing picture of primary hyperparathyroidism in the years 1956–1979. Ann Chir Gynaecol 73(6):319–324PubMed
40.
Zurück zum Zitat Heath H (1991) Clinical spectrum of primary hyperparathyroidism: evolution with changes in medical practice and technology. J Bone Miner Res 6(Suppl 2):S63–S70 (discussion S83–S84) PubMed Heath H (1991) Clinical spectrum of primary hyperparathyroidism: evolution with changes in medical practice and technology. J Bone Miner Res 6(Suppl 2):S63–S70 (discussion S83–S84) PubMed
Metadaten
Titel
Changing Profile of Primary Hyperparathyroidism Over Two and Half Decades: A Study in Tertiary Referral Center of North India
verfasst von
Sanjay Kumar Yadav
Saroj Kanta Mishra
Anjali Mishra
Sabaretnam Mayilvagnan
Gyan Chand
Gaurav Agarwal
Amit Agarwal
Ashok Kumar Verma
Publikationsdatum
16.03.2018
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 9/2018
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-018-4575-0

Weitere Artikel der Ausgabe 9/2018

World Journal of Surgery 9/2018 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.